Close Menu

NEW YORK (GenomeWeb) – Qiagen said yesterday that it has received US Food and Drug Administration Clearance for its Ipsogen JAK2 RGQ real-time PCR kit to aid in the diagnosis of the blood cancer polycythemia vera.

The qualitative in vitro diagnostic test runs on Qiagen's Rotor-Gene Q MDx system and is designed to qualitatively detect the JAK2 V617F/G1849T allele in genomic DNA extracted from EDTA whole blood.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.